Section 510(k) of the U.S. Food, Drug, and Cosmetic Act requires manufacturers of certain medical devices to notify the FDA at least 90 days in advance of their intent to market a medical device. This is known as Premarket Notification, or PMN, also referred to as 510(k). This notification allows the FDA to determine whether the device is substantially equivalent to devices already classified under one of three classification categories. As a result, “new” devices that have not been previously classified (those not commercially distributed before May 28, 1976) can be accurately identified. Specifically, a 510(k) is required if a manufacturer intends to commercially distribute a device for the first time or reintroduce a device with significant changes or modifications that could impact its safety or effectiveness. These changes or modifications may relate to the device’s design, materials, chemical composition, energy source, manufacturing process, or intended use.
Any Class I, II, or III medical device intended for sale in the U.S. must submit a 510(k) to the FDA, unless the device qualifies for a 510(k) exemption under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The requirements for 510(k) submissions are outlined in 21 CFR 807 E. Prior to marketing the device, the submitter must receive a letter from the FDA confirming that the device is substantially equivalent (SE) to a legally marketed device of the same type that has already been cleared for sale in the U.S.
Collaborate with global partners to provide technical documentation compliant with ISO, GLP, and FDA regulations, including the testing data required for medical device submissions. Utilize known data to establish a complete data chain for regulatory authorities, ensuring that medical device data is clear and controllable for submission to regulatory agencies.

